IL-6 drugs do work in COVID-19, says UK, as it plans NHS useNew data means that IL-6 drugs from Roche and Sanofi that had been all-but written off as coronavirus Share XIL-6 drugs do work in COVID-19, says UK, as it plans NHS usehttps://pharmaphorum.com/news/il-6-drugs-covid-19-new-trial/
Vulnerable should all get COVID-19 shot before summer, says NHS chiefNHS England’s chief executive Sir Simon Stevens has said that all vulnerable people over the age of 50 Share XVulnerable should all get COVID-19 shot before summer, says NHS chiefhttps://pharmaphorum.com/news/vulnerable-should-all-get-covid-19-shot-before-summer-says-nhs-chief/
Amgen hands off leprosy, TB candidate to Australian non-profitAmgen has decided that a drug for leprosy and tuberculosis it inherited as part of its acquisition of Share XAmgen hands off leprosy, TB candidate to Australian non-profithttps://pharmaphorum.com/news/amgen-hands-off-leprosy-tb-candidate-to-australian-non-profit/
NHS leaders urge UK government to extend Brexit transition periodNHS leaders have written to the UK prime minister urging him to extend the Brexit transition period by Share XNHS leaders urge UK government to extend Brexit transition periodhttps://pharmaphorum.com/news/nhs-uk-extend-brexit-transition/
Pandemic has little impact on pharma’s reputation, says reportThe pandemic has had very little positive impact on the public’s perceptions of pharma although the industry has Share XPandemic has little impact on pharma’s reputation, says reporthttps://pharmaphorum.com/news/pandemic-has-little-impact-on-pharmas-reputation-says-report/
Social media erupts as anti-vaxxers respond to COVID-19 vaccine approvalIn the midst of the jubilation about the UK’s emergency approval of Pfizer/BioNTech’s COVID-19 shot in the UK Share XSocial media erupts as anti-vaxxers respond to COVID-19 vaccine approvalhttps://pharmaphorum.com/news/social-media-erupts-as-anti-vaxxers-respond-to-covid-19-vaccine-approval/
Takeda to partner on patient-centric data with SeqsterTakeda has partnered with patient data firm Seqster in a drive to improve care through better access and Share XTakeda to partner on patient-centric data with Seqsterhttps://pharmaphorum.com/news/takeda-to-partner-on-patient-centric-data-with-seqster/
NICE changes its mind on Novartis’ progressive MS drug MayzentUK cost-effectiveness agency NICE has backed Novartis’ Mayzent for secondary progressive multiple sclerosis (SPMS), after turning it down Share XNICE changes its mind on Novartis’ progressive MS drug Mayzenthttps://pharmaphorum.com/news/nice-changes-its-mind-on-novartis-progressive-ms-drug-mayzent/
Roche working “around the clock” to tackle UK test supply problemsSupplies of swabs for coronavirus and other critical NHS tests for diseases like cancer, diabetes and heart disease Share XRoche working “around the clock” to tackle UK test supply problemshttps://pharmaphorum.com/news/roche-working-around-the-clock-to-tackle-uk-test-problems/
